{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:24:23Z","timestamp":1794007463297,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41433-021-01573-3","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T14:02:47Z","timestamp":1624024967000},"page":"29-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt\u2013Koyanagi\u2013Harada disease: an updated review"],"prefix":"10.1038","volume":"36","author":[{"suffix":"Jr","given":"Carl P.","family":"Herbort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-453X","authenticated-orcid":false,"given":"Ilknur","family":"Tugal-Tutkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abu-El-Asrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8427-5738","authenticated-orcid":false,"given":"Amod","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fardeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Hedayatfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian","family":"Urzua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Papasavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"1573_CR1","first-page":"2004","volume":"42","author":"K Gocho","year":"2001","unstructured":"Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Investig Ophthalmol Vis Sci. 2001;42:2004\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1573_CR2","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1167\/iovs.04-1273","volume":"46","author":"FM Damico","year":"2005","unstructured":"Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Investig Ophthalmol Vis Sci. 2005;46:2465\u201371.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1573_CR3","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1167\/iovs.05-1547","volume":"47","author":"S Sugita","year":"2006","unstructured":"Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T. et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Investig Ophthalmol Vis Sci. 2006;47:2547\u201354.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1573_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0412-4","volume":"11","author":"MM Lavezzo","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29.","journal-title":"Orphanet J Rare Dis"},{"key":"1573_CR5","first-page":"364","volume":"20","author":"MM Yokoyama","year":"1981","unstructured":"Yokoyama MM, Matsui Y, Yamashiroya HM, O\u2019Donnell MJ, Tseng CH, Snyder DA, et al. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis. Investig Ophthalmol Vis Sci. 1981;20:364\u201370.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1573_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00917833","volume":"18","author":"VT Tran","year":"1994","unstructured":"Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18:293\u20138.","journal-title":"Int Ophthalmol"},{"key":"1573_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1001\/archopht.1996.01100140384003","volume":"114","author":"S Nakamura","year":"1996","unstructured":"Nakamura S, Nakazawa M, Yoshioka M, Nagano I, Nakamura H, Onodera J, et al. Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol. 1996;114:1184\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1573_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/00016489.2013.868604","volume":"134","author":"Y Noguchi","year":"2014","unstructured":"Noguchi Y, Nishio A, Takase H, Miyanaga M, Takahashi H, Mochizuki M, et al. Audiovestibular findings in patients with Vogt-Koyanagi-Harada disease. Acta Otolaryngol. 2014;134:339\u201344.","journal-title":"Acta Otolaryngol"},{"key":"1573_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0171-3","volume":"15","author":"K Hirooka","year":"2015","unstructured":"Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, et al. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015;15:181.","journal-title":"BMC Ophthalmol"},{"key":"1573_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/02713680802233968","volume":"33","author":"W Fang","year":"2008","unstructured":"Fang W, Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res. 2008;33:517\u201323.","journal-title":"Curr Eye Res"},{"key":"1573_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10792-016-0395-0","volume":"37","author":"CP Herbort Jr","year":"2017","unstructured":"Herbort CP Jr, Asrar AMAbuEL, Yamamoto JH, Pavesio CE, Gupta V, Khairallah M, et al. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol. 2017;37:1383\u201395.","journal-title":"Int Ophthalmol"},{"key":"1573_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/OPTH.S134977","volume":"11","author":"SAK Lodhi","year":"2017","unstructured":"Lodhi SAK, Reddy JML, Peram V. Clinical spectrum and management options in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2017;11:1399\u2013406.","journal-title":"Clin Ophthalmol"},{"key":"1573_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-00214-2","volume":"14","author":"CA Urzua","year":"2020","unstructured":"Urzua CA, Herbort CP Jr, Valenzuela RA, Abu E-Asrar AM, Arellanes-Garcia L, Schlaen A, et al. Initial-onset acute and chronic stages are two distinctive courses of Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect. 2020;14:23.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1573_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647\u201352.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.joco.2018.10.011","volume":"31","author":"A Hedayatfar","year":"2018","unstructured":"Hedayatfar A, Khochtali S, Khairallah M, Takeuchi M, El-Asrar AA, Herbort CP Jr. \u201cRevised diagnostic criteria\u201d for Vogt-Koyanagi-Harada disease fail to improve disease management. J Curr Ophthalmol. 2018;31:1\u20137.","journal-title":"J Curr Ophthalmol"},{"key":"1573_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0161-6420(00)00428-0","volume":"108","author":"N Bouchenaki","year":"2001","unstructured":"Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001;108:54\u201364.","journal-title":"Ophthalmology"},{"key":"1573_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00417-011-1910-7","volume":"250","author":"K Nakai","year":"2012","unstructured":"Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:1089\u201395.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1573_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10792-018-0949-4","volume":"39","author":"CarlP Herbort Jr","year":"2019","unstructured":"Herbort CarlP Jr, Abu El Asrar AhmedM, Takeuchi Masuru, Pav\u00e9sio CarlosE, Couto Cristobal, Hedayatfa Alireza, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. Int Ophthalmol. 2019;39:1419\u201325.","journal-title":"Int Ophthalmol"},{"key":"1573_CR19","unstructured":"Vogt A, Fr\u00fchzeitiges ergrauen der Zilien und Bermerkungen \u00fcber den sogenannten pl\u00f6tzlichen Eintritt dieser Ver\u00e4nderung. Klin Monbl Augenheilkd, 1906;44:228\u201342."},{"key":"1573_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10792-007-9083-4","volume":"27","author":"CP Herbort","year":"2007","unstructured":"Herbort CP, Mochizuki M. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol. 2007;27:67\u201379.","journal-title":"Int Ophthalmol"},{"key":"1573_CR21","unstructured":"Koyanagi Y. Nippon Ganka Gakkai Zasshi, 1914;18:1188."},{"key":"1573_CR22","unstructured":"Harada E. Jikken Ganka Zasshi 1918;2:199."},{"key":"1573_CR23","first-page":"356","volume":"30","author":"E Harada","year":"1926","unstructured":"Harada E. Beitrag zur klinischen Kenntnis von nichteitriger Choroiditis (choroiditis diffusa acta). Acta Soc Ophthalmol Jpn. 1926;30:356\u201378.","journal-title":"Acta Soc Ophthalmol Jpn"},{"key":"1573_CR24","unstructured":"Koyanagi Y. Dysakusis, alopecia und poliosis bei schwerer uveitis nicht traumatischen ursprungs. Klin Monbl Augenheilkd. 1929;82:228\u201342."},{"key":"1573_CR25","unstructured":"Babel J. Syndrome de Vogt-Koyanagi (Uveite bilateral, poliosis, alopecie, vitiligo et dysacousie). Schweiz Med Wochenschr. 1932;44:1136\u201340."},{"key":"1573_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0002-9394(49)90876-4","volume":"32","author":"MM Bruno","year":"1949","unstructured":"Bruno MM, McPherson SD Jr. Harada\u2019s disease. Am J Ophthalmol. 1949;32:513\u201322.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR27","first-page":"219","volume":"28","author":"N Maezawa","year":"1984","unstructured":"Maezawa N, Yano A. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harda disease that recognize human melanoma cells. MicrobiolImmunol. 1984;28:219\u201331.","journal-title":"MicrobiolImmunol"},{"key":"1573_CR28","first-page":"1210","volume":"31","author":"K Norose","year":"1990","unstructured":"Norose K, Yano A, Aosai F, Segawa K. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease. Investig Ophthalmol Vis Sci. 1990;31:1210\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1573_CR29","first-page":"451","volume":"79","author":"H Reed","year":"1958","unstructured":"Reed H, Lindsay A, Silversides JL, Speakman J, Monckton G, Rees DL. The uveo-encephalitic syndrome or Vogt-Koyanagi-Harada disease. Can MedAssoc J. 1958;79:451\u20139.","journal-title":"Can MedAssoc J"},{"key":"1573_CR30","first-page":"553","volume":"23","author":"K Masuda","year":"1969","unstructured":"Masuda K, Tanishima T. Early treatment of Harada\u2019s disease. Jpn J Clin Ophthalmol. 1969;23:553.","journal-title":"Jpn J Clin Ophthalmol"},{"key":"1573_CR31","first-page":"1053","volume":"38","author":"S Kotake","year":"1984","unstructured":"Kotake S, Ohno S. Pulse methyl prednisolone therapy in the treatment of Vogt-Koyanagi-Harada disease. Jpn J Clin Ophthalmol. 1984;38:1053\u20138.","journal-title":"Jpn J Clin Ophthalmol"},{"key":"1573_CR32","first-page":"9","volume":"22","author":"S Sugiura","year":"1978","unstructured":"Sugiura S. Vogt-Koyanagi-Harada Disease. Jpn J Ophthalmol. 1978;22:9\u201335.","journal-title":"Jpn J Ophthalmol"},{"key":"1573_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9394(14)75078-0","volume":"90","author":"DA Snyder","year":"1980","unstructured":"Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90:69\u201375.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR34","first-page":"169","volume":"2","author":"CP Herbort","year":"1994","unstructured":"Herbort CP, Guex-Crosier Y, LeHoang P. Schematic interpretation of indocyanine green angiography. Ophthalmology. 1994;2:169\u201376.","journal-title":"Ophthalmology"},{"key":"1573_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/02713689008999417","volume":"9","author":"H Inomata","year":"1990","unstructured":"Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res. 1990;9:35\u201340.","journal-title":"Curr Eye Res"},{"key":"1573_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/exer.2000.0893","volume":"71","author":"K Yamaki","year":"2000","unstructured":"Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and axtraocular inflammation induced by immunazation of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res. 2000;71:361\u201369.","journal-title":"Exp Eye Res"},{"key":"1573_CR37","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.4049\/jimmunol.165.12.7323","volume":"165","author":"K Yamaki","year":"2000","unstructured":"Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada. J Immunol. 2000;165:7323\u20139.","journal-title":"J Immunol"},{"key":"1573_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/bjo.78.3.223","volume":"78","author":"Y Shindo","year":"1994","unstructured":"Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994;78:223\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1573_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1755-3768.2009.01757.x","volume":"88","author":"M Mochizuki","year":"2010","unstructured":"Mochizuki M. Regional immunity of the eye. Acta Ophthalmol. 2010;88:292\u201399.","journal-title":"Acta Ophthalmol"},{"key":"1573_CR40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2018.00622","volume":"9","author":"P Musette","year":"2018","unstructured":"Musette P, Bouaziz JD. B cell modulation strategies in autoimmune diseases: new concepts. Front Immunol. 2018;9:622.","journal-title":"Front Immunol"},{"key":"1573_CR41","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1167\/iovs.17-23225","volume":"59","author":"AM Abu El-Asrar","year":"2018","unstructured":"Abu El-Asrar AM, Bergman N, Al-Obeidan SA, et al. Differential CXC and CX3C chemokine expression profiles in aqueous humor of patients with specific endogenous uveitic entities. Investig Opthalmol Vis Sci. 2018;59:2222\u20138.","journal-title":"Investig Opthalmol Vis Sci"},{"key":"1573_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/09273948.2019.1604974","volume":"28","author":"AM Abu El-Asrar","year":"2020","unstructured":"Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, et al. Local cytokine expression profiling in patients with specific autoimmune uveitic entities. Ocul Immunol Inflamm. 2020;28:453\u201362.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0002-9394(88)90052-9","volume":"105","author":"CC Chan","year":"1988","unstructured":"Chan CC, Palestine AG, Kuwabara T, Nussenblatt RB. Immunopathologic study of Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1988;105:607\u201311.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR44","first-page":"1","volume":"29","author":"AM Abu El-Asrar","year":"2020","unstructured":"Abu El-Asrar AM, Dheyab A, Khatib D, Struyf S, Van Damme J, Opdenakker G. Efficacy of B cell depletion therapy with rituximab in refractory chronic recurrent uveitis associated with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2020;29:1\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.sjopt.2013.10.003","volume":"28","author":"M Khairallah","year":"2014","unstructured":"Khairallah M. Headache as an initial manifestation of Vogt-Koyanagi-Harada disease. Saudi J Ophthalmol. 2014;28:239\u201342.","journal-title":"Saudi J Ophthalmol"},{"key":"1573_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000117802","volume":"17","author":"KK Kosma","year":"2008","unstructured":"Kosma KK, Kararizou E, Markou I, Eforakopoulou E, Kararizos G, Mitsonis C, et al. Headache as a first manifestation of Vogt-Koyanagi-Harada disease. Med Princ Pr. 2008;17:253\u20134.","journal-title":"Med Princ Pr"},{"key":"1573_CR47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1046\/j.1468-1331.2000.00156.x","volume":"7","author":"A Kamondi","year":"2000","unstructured":"Kamondi A, Szegedi A, Papp A, Sees A, Szirmmai I. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol. 2000;7:719\u201322.","journal-title":"Eur J Neurol"},{"key":"1573_CR48","doi-asserted-by":"publisher","unstructured":"Almalki K, Alsulaiman SM, Abouammoh A. Internal limiting membrane folds as a presenting sign in acute initial-onset Vogt-Koyanagi-Harada disease: a case report. Ocul Immunol Inflamm 2020; https:\/\/doi.org\/10.1080\/09273948.2020.1828489.","DOI":"10.1080\/09273948.2020.1828489"},{"key":"1573_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10792-006-9024-7","volume":"27","author":"C Fardeau","year":"2007","unstructured":"Fardeau C, Tran TH, Gharbi B, Cassoux N, Bodaghi B, LeHoang P. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27:163\u201372.","journal-title":"Int Ophthalmol"},{"key":"1573_CR50","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","volume":"114","author":"P Yang","year":"2007","unstructured":"Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606\u201314.","journal-title":"Ophthalmology"},{"key":"1573_CR51","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1111\/aos.12127","volume":"91","author":"AM Abu El-Asrar","year":"2013","unstructured":"Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91:e486\u2013e493.","journal-title":"Acta Ophthalmol"},{"key":"1573_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10792-007-9052-y","volume":"27","author":"A Mantovani","year":"2007","unstructured":"Mantovani A, Resta A, Herbort CP, Abu El Asrar A, Kawaguchi T, Mochizuki M, et al. Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopisation with granulomatous uveitis. Int Ophthalmol. 2007;27:105\u201315.","journal-title":"Int Ophthalmol"},{"key":"1573_CR53","unstructured":"Bouchenaki N, Herbort CP. Stromal choroiditis. In: Pleyer U, Mondino B, editors Essentials in Ophthalmology: Uveitis and Immunological Disorders. Berlin, Heidelberg, New York: Springer; 2004 pp 234\u201353."},{"key":"1573_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2002-30661","volume":"219","author":"N Bouchenaki","year":"2002","unstructured":"Bouchenaki N, Cimino L, Auer C, Tran VT, Herbort CP. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd. 2002;219:243\u20139.","journal-title":"Klin Monbl Augenheilkd"},{"key":"1573_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/jovr.jovr_201_17","volume":"13","author":"A El Ameen","year":"2018","unstructured":"El Ameen A, Herbort CP Jr. Comparison of retinal and choroidal involvement in sarcoidosis related chorioretinitis using fluorescein and indocyanine green angiography. J Ophthalmic Vis Res. 2018;13:426\u201332.","journal-title":"J Ophthalmic Vis Res"},{"key":"1573_CR56","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1055\/a-0829-6763","volume":"236","author":"S Elahi","year":"2019","unstructured":"Elahi S, Herbort CP Jr. Vogt-Koyanagi-Harada disease and birdshot retinochoroiditis, similarities and differences: a glimpse into the clinicopathology of stromal choroiditis, a perspective and a review. Klin Monbl Augenheilkd. 2019;236:492\u2013510.","journal-title":"Klin Monbl Augenheilkd"},{"key":"1573_CR57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1586\/eop.12.63","volume":"7","author":"S Attia","year":"2012","unstructured":"Attia S, Khochtali S, Kahloum R, Zouali S, Khairallah M. Vogt-Koyanagi-Harada disease. Expert Rev Ophthalmol. 2012;7:565\u201385.","journal-title":"Expert Rev Ophthalmol"},{"key":"1573_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1751-1097.2008.00316.x","volume":"84","author":"DN Hu","year":"2008","unstructured":"Hu DN, Simon JD, Sarna T. Role of ocular melanin in ophthalmic physiology and pathology. Photochem Photobio. 2008;84:639\u201344.","journal-title":"Photochem Photobio"},{"key":"1573_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0002-9394(65)94795-1","volume":"59","author":"MI Kaczurowski","year":"1965","unstructured":"Kaczurowski MI. The pigment elements of the human iris and ciliary body. Am J Opthalmol. 1965;59:299\u2013308.","journal-title":"Am J Opthalmol"},{"key":"1573_CR60","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ajo.2007.10.012","volume":"145","author":"K Bascal","year":"2008","unstructured":"Bascal K, Wen DS, Chee SP. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2008;145:480\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-12-40","volume":"12","author":"FT da Silva","year":"2012","unstructured":"da Silva FT, Hirata CE, Sakata VM, Olivalves E, Preti R, Pimentel SLG, et al. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harad disease: a cross-sectional study. BMC Ophthalmol. 2012;12:40.","journal-title":"BMC Ophthalmol"},{"key":"1573_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10792-008-9288-1","volume":"30","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Horie S, Bouchenaki N, Ohno-Matsui K, Mochizuki M, Herbort CP. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2010;30:41\u201350.","journal-title":"Int Ophthalmol"},{"key":"1573_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/bjophthalmol-2012-302089","volume":"97","author":"FT da Silva","year":"2013","unstructured":"da Silva FT, Sakata VM, Nakashima A, Hirata CE, Olivalves E, Takahashi WY, et al. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013;97:70\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1573_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000481863","volume":"239","author":"YS Han","year":"2018","unstructured":"Han YS, Shin KS, Lee WH, Kim JY. Changes in central macular thickness and retinal nerve fiber layer thickness in eyes with Vogt-Koyanagi-Harada disease: a 2-year follow-up study. Ophthalmologica. 2018;239:143\u201350.","journal-title":"Ophthalmologica"},{"key":"1573_CR65","doi-asserted-by":"publisher","first-page":"3853794","DOI":"10.1155\/2019\/3853794","volume":"2019","author":"T Murata","year":"2019","unstructured":"Murata T, Sako N, Takayama K, Harimoto K, Kanda K, Herbort CP Jr, et al. Identification of underlying inflammation in Vogt-Koyanagi-Harada disease with sunset glow fundus by multiple analyses. J Ophthalmol. 2019;2019:3853794. eCollection 2019","journal-title":"J Ophthalmol"},{"key":"1573_CR66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/09273948.2016.1139730","volume":"25","author":"AM Abu El-Asrar","year":"2017","unstructured":"Abu El-Asrar AM, Al Mudhaiyan T, Al Najashi AA, Hemachandran S, Hariz R, Mousa A, et al. Chronic recurrent Vogt-Koyanagi-Harada disease and development of \u201csunset glow fundus predict worse retinal sensitivity. Ocul Immunol Inflamm. 2017;25:475\u201385.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9394(01)00937-0","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Rechodouni A, Butani N, Johnston R, LaBree D, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131:599\u2013606.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR68","doi-asserted-by":"publisher","unstructured":"Golzarri MF, Cheja-Kalb R, Concha-Del-Rio LE, Gonzales-Salinas R, Arellanes-Garcia L Risk factors for subretinal fibrosis in patients with Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm 2020;1\u20135. https:\/\/doi.org\/10.1080\/09273948.2020.1825750.","DOI":"10.1080\/09273948.2020.1825750"},{"key":"1573_CR69","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","volume":"136","author":"P Yang","year":"2018","unstructured":"Yang P, Zhong Y, Du L, Chi W, Chen L, Zhang R, et al. Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease. JAMA Ophthalmol. 2018;136:1025\u201331.","journal-title":"JAMA Ophthalmol"},{"key":"1573_CR70","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/bjophthalmol-2018-312569","volume":"103","author":"P Kim","year":"2019","unstructured":"Kim P, Sun HJ, Ham DI. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harad disease. Br J Ophthalmol. 2019;103:942\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1573_CR71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10792-017-0487-5","volume":"38","author":"O Balci","year":"2018","unstructured":"Balci O, Jeannin B, Herbort CP. Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot choriretinitis and Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2018;38:527\u201339.","journal-title":"Int Ophthalmol"},{"key":"1573_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/aos.12974","volume":"94","author":"MA Abouammoh","year":"2016","unstructured":"Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disese. Acta Ophthalmol. 2016;94:573\u20138.","journal-title":"Acta Ophthalmol"},{"key":"1573_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10384-010-0853-6","volume":"54","author":"M Miyanaga","year":"2010","unstructured":"Miyanaga M, Kawaguchi T, Miyata K, Horie S, Mochizuki M, Herbort CP. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol. 2010;54:377\u201382.","journal-title":"Jpn J Ophthalmol"},{"key":"1573_CR74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/09273948.2016.1195001","volume":"26","author":"k Aggarwal","year":"2018","unstructured":"Aggarwal k, Agarwal A, Mahajan S, Invernizzi A, SKR Mandadi, et al. OCTA Study Group. The role of Optical Coherence Tomography Angiography in the diagnosis and management of acute Vogt-Koyanagi-Harada diseases. Ocul Immunol Inflamm. 2018;26:142\u201353.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR75","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/JOCO.JOCO_190_20","volume":"32","author":"I Papasavvas","year":"2020","unstructured":"Papasavvas I, Tugal-Tutkun I, Herbort CP Jr. Vogt-Koyanagi-Harada disease is a curable autoimmune disease: early diagnosis and dual steroidal and non-steroidal immunosuppression are crucial prerequisites. J Curr Ophthalmol. 2020;32:310\u201314.","journal-title":"J Curr Ophthalmol"},{"key":"1573_CR76","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1111\/j.1755-3768.2012.02498.x","volume":"90","author":"AM Abu El-Asrar","year":"2012","unstructured":"Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2012;90:e603\u2013e608.","journal-title":"Acta Ophthalmol"},{"key":"1573_CR77","first-page":"241","volume":"6","author":"N Bouchenaki","year":"2011","unstructured":"Bouchenaki N, Herbort CP. Indocyanine green angiography guided management of Vogt-Koyanagi-Harada disease. J Ophthalmic Vis Res. 2011;6:241\u20138.","journal-title":"J Ophthalmic Vis Res"},{"key":"1573_CR78","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10792-016-0303-7","volume":"37","author":"O Balci","year":"2016","unstructured":"Balci O, Gasc A, Jeannin B, Herbort CP Jr. (2016) Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot study. Int Ophthalmol. 2016;37:737\u201348.","journal-title":"Int Ophthalmol"},{"key":"1573_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1055\/s-2000-10987","volume":"216","author":"N Bouchenaki","year":"2000","unstructured":"Bouchenaki N, Morisod L, Herbort CP. Vogt-Koyanagi-Harada syndrome: Importance of rapid diagnosis and therapeutic intervention. Klin Monbl Augenheilkd. 2000;216:290\u20134.","journal-title":"Klin Monbl Augenheilkd"},{"key":"1573_CR80","first-page":"98","volume":"10","author":"VE Giordano","year":"2017","unstructured":"Giordano VE, Schlaen A, Guzman-Sanchez MJ, Couto C. Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina. Int J Ophthalmol. 2017;10:98\u2013102.","journal-title":"Int J Ophthalmol"},{"key":"1573_CR81","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00417-017-3654-5","volume":"255","author":"UC Park","year":"2017","unstructured":"Park UC, Cho IH, Lee EK, Yu HG. The effect on choroidal changes of the route of systemic corticosteroids in Acute Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2017;255:1203\u201311.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1573_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10792-006-9009-6","volume":"27","author":"SP Chee","year":"2007","unstructured":"Chee SP, Jap A, Bascal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol. 2007;27:137\u201342.","journal-title":"Int Ophthalmol"},{"key":"1573_CR83","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00417-014-2904-z","volume":"253","author":"VM Sakata","year":"2015","unstructured":"Sakata VM, da Silva FT, Hirata CE, Marin ML, Rodrigues H, Kalil J, et al. High-rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol. 2015;253:785\u201390.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1573_CR84","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00417-002-0538-z","volume":"240","author":"H Keino","year":"2002","unstructured":"Keino H, Goto H, Usui M. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefe\u2019s Arch Clin Exp Ophthalmol. 2002;240:878\u201382.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1573_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/aos.13189","volume":"95","author":"AM Abu EL-Asrar","year":"2017","unstructured":"Abu EL-Asrar AM, Dosari M, Hemachandran S, Hikandi PW, Al-Muamar A. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of \u201csunset glow fundus\u201d in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2017;95:85\u201390.","journal-title":"Acta Ophthalmol"},{"key":"1573_CR86","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s10792-020-01417-1","volume":"40","author":"CP Herbort Jr","year":"2020","unstructured":"Herbort CP Jr, Tugal-Tutkun I, Khairallah M, Abu EL-Asrar AM, Pav\u00e9sio CE, Soheilian M. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modalities and geographic area. Int Ophthalmol. 2020;40:2423\u201333.","journal-title":"Int Ophthalmol"},{"key":"1573_CR87","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/02713683.2017.1383444","volume":"43","author":"P Yang","year":"2018","unstructured":"Yang P, Ye Z, Zhou Q, Qi J, Liang L, Wu L. et alNovel treatment regimen of Vogt-Koyanagi-Harada disease with reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018;43:254\u201361.","journal-title":"Curr Eye Res"},{"key":"1573_CR88","first-page":"474","volume":"121","author":"M Haruta","year":"2017","unstructured":"Haruta M, Yoshioka M, Fukutomi A, Minami T, Mashimo H, Shimojo H, et al. The effect of low-dose cyclosporine (100 mg once daily) for chronic Vogt-Koyanagi-Harada disease. Nippon Ganka Gakkai Zasshi. 2017;121:474\u20139.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1573_CR89","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/09273940701624312","volume":"15","author":"HG Yu","year":"2007","unstructured":"Yu HG, Kim SJ. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2007;15:381\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR90","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ajo.2016.06.004","volume":"168","author":"E Shen","year":"2016","unstructured":"Shen E, Rathinam SR, Babu M, Kanakath A, Thundikandy R, Lee SM, et al. Outcomes of Vogt-Koyanagi-Harada disease: a subanalysis from a randomizes clinical trial of antimetabolite therapies. Am J Ophthalmol. 2016;168:279\u201386.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR91","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/09273948.2016.1236969","volume":"26","author":"C Couto","year":"2018","unstructured":"Couto C, Schlaen A, Frick M, Khoury M, Lopez M, Hurtado E, et al. Adalumimab treatment in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2018;26:485\u20139.","journal-title":"Ocul Immunol Inflamm"},{"key":"1573_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12348-011-0027-9","volume":"1","author":"R Dolz-Marco","year":"2011","unstructured":"Dolz-Marco R, Gallego-Pinazo R, Diaz-Llopis M. Rituximab in refractory Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect. 2011;1:177\u201380.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1573_CR93","doi-asserted-by":"publisher","first-page":"b2480","DOI":"10.1136\/bmj.b2480","volume":"339","author":"JH Kempen","year":"2009","unstructured":"Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ 2009;339:b2480.","journal-title":"BMJ"},{"key":"1573_CR94","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","volume":"118","author":"JH Kempen","year":"2011","unstructured":"Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 2011;118:1916\u201326.","journal-title":"Ophthalmology"},{"key":"1573_CR95","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjophthalmol-2014-306439","volume":"100","author":"Y Tagawa","year":"2016","unstructured":"Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, et al. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016;100:473\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1573_CR96","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/bjophthalmol-2015-308091","volume":"101","author":"A Jap","year":"2017","unstructured":"Jap A, Chee SP. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2017;101:186\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1573_CR97","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajo.2006.01.017","volume":"141","author":"H Keino","year":"2006","unstructured":"Keino H, Goto H, Mori H, Iwasaki T, Usui M. Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2006;141:1140\u201342.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR98","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10792-007-9076-3","volume":"27","author":"M Miyanaga","year":"2007","unstructured":"Miyanaga M, Kawaguchi T, Shimizu K, Miyata K, Mochizuku M. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27:183\u20138.","journal-title":"Int Ophthalmol"},{"key":"1573_CR99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","volume":"142","author":"RW Read","year":"2006","unstructured":"Read RW, Yu F, Accorinti Bodaghi B, Chee SP, Fardeau C, Goto H, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2006;142:119\u201324.","journal-title":"Am J Ophthalmol"},{"key":"1573_CR100","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09273940802204527","volume":"16","author":"Y Wang","year":"2008","unstructured":"Wang Y, Gaudio PA. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2008;16:167\u201371.","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01573-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01573-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01573-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T06:07:12Z","timestamp":1675490832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01573-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1573"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01573-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}